HA Drug Formulary
Version 21.4 – with effect from 25 April 2026
- The drugs may either be listed as generic or proprietary names, where appropriate. Brand names listed serve as reference only, they do not necessarily indicate the availability of that particular brand.
- Some drugs may appear in more than one category due to different formulations and/or indications.
- The "Special" drugs will be prescribed as clinically indicated based on the specified indications.
- Based on operational logistics and needs, individual cluster/hospital may only stock part of the drugs listed on the HA Drug Formulary.
| General Drugs | Special Drugs | Self-financed Items with Safety Net |
Self-financed Items without Safety Net |
|---|---|---|---|
 Cardiovascular
|
|||
| General Drugs | Special Drugs | Self-financed Items with Safety Net |
Self-financed Items without Safety Net |
| POSITIVE INOTROPIC DRUGS | |||
| DIGOXIN | MILRINONE | ||
| DIURETICS | |||
| AMILORIDE | EPLERENONE | ||
| BUMETANIDE | FINERENONE | ||
| DYAZIDE (OR EQUIV) | |||
| FRUSEMIDE | |||
| HYDROCHLOROTHIAZIDE | |||
| INDAPAMIDE | |||
| MANNITOL | |||
| MANNITOL + SORBITOL | |||
| METOLAZONE | |||
| MODURETIC (OR EQUIV) | |||
| SPIRONOLACTONE | |||
| ANTI-ARRHYTHMIC DRUGS | |||
| AMIODARONE | DRONEDARONE | ||
| ATROPINE | |||
| DISOPYRAMIDE | |||
| FLECAINIDE | |||
| MEXILETINE | |||
| PROCAINAMIDE | |||
| PROPAFENONE | |||
| QUINIDINE | |||
| BETA-ADRENOCEPTOR BLOCKING DRUGS | |||
| ATENOLOL | |||
| BISOPROLOL | |||
| BISOPROLOL + HYDROCHLOROTHIAZIDE | |||
| CARVEDILOL | |||
| ESMOLOL | |||
| LABETALOL | |||
| METOPROLOL | |||
| NADOLOL | |||
| PROPRANOLOL | |||
| SOTALOL | |||
| HYPERTENSION AND HEART FAILURE | |||
| CAPTOPRIL | AMBRISENTAN | ||
| CLONIDINE | AMLODIPINE + VALSARTAN | ||
| ENALAPRIL | BOSENTAN | ||
| ENALAPRILAT | CANDESARTAN | ||
| HYDRALAZINE | DOXAZOSIN | ||
| LISINOPRIL | ILOPROST | ||
| LOSARTAN | IRBESARTAN | ||
| METHYLDOPA | IRBESARTAN + HYDROCHLOROTHIAZIDE | ||
| MINOXIDIL | LOSARTAN + HYDROCHLOROTHIAZIDE | ||
| NITROPRUSSIDE DIHYDRATE SODIUM | MACITENTAN | ||
| PERINDOPRIL | RIOCIGUAT | ||
| PHENOXYBENZAMINE | SACUBITRIL + VALSARTAN | ||
| PHENTOLAMINE | SELEXIPAG | ||
| PRAZOSIN | SILDENAFIL (REVATIO) | ||
| RAMIPRIL | TELMISARTAN + HYDROCHLOROTHIAZIDE | ||
| TELMISARTAN | VALSARTAN | ||
| TERAZOSIN | VALSARTAN + HYDROCHLOROTHIAZIDE | ||
| NITRATES, CALCIUM-CHANNEL BLOCKERS, AND OTHER ANTIANGINAL DRUGS | |||
| AMLODIPINE | CILOSTAZOL | CEREBROLYSIN (OR EQUIV) | |
| DILTIAZEM | GINKGO BILOBA EXTRACT | ||
| FELODIPINE ER | IVABRADINE | ||
| GLYCERYL TRINITRATE | LERCANIDIPINE | ||
| GLYCERYL TRINITRATE (PATCH) | NIFEDIPINE | ||
| ISOSORBIDE DINITRATE | OXPENTIFYLLINE | ||
| ISOSORBIDE MONONITRATE | |||
| NICARDIPINE | |||
| NICERGOLINE | |||
| NIFEDIPINE | |||
| NIMODIPINE | |||
| VERAPAMIL | |||
| SYMPATHOMIMETICS | |||
| ADRENALINE | |||
| DOBUTAMINE | |||
| DOPAMINE | |||
| EPHEDRINE | |||
| ISOPRENALINE | |||
| MIDODRINE | |||
| NORADRENALINE | |||
| PHENYLEPHRINE | |||
| ANTICOAGULANTS AND PROTAMINE | |||
| ARGATROBAN | APIXABAN | ||
| ENOXAPARIN | DABIGATRAN | ||
| EPOPROSTENOL | EDOXABAN | ||
| HEPARIN | RIVAROXABAN | ||
| NADROPARIN | |||
| PROTAMINE SULPHATE | |||
| TINZAPARIN | |||
| WARFARIN | |||
| ANTIPLATELET DRUGS | |||
| ASPIRIN | CLOPIDOGREL | ||
| ASPIRIN + GLYCINE | EPTIFIBATIDE | ||
| DIPYRIDAMOLE | PRASUGREL | ||
| TICAGRELOR | |||
| STABLE ANGINA, ACUTE CORONARY SYNDROMES, AND FIBRINOLYSIS | |||
| ALTEPLASE | |||
| TENECTEPLASE | |||
| UROKINASE | |||
| ANTIFIBRINOLYTIC DRUGS AND HAEMOSTATICS | |||
| TRANEXAMIC ACID | EFANESOCTOCOG ALFA | ||
| EMICIZUMAB | |||
| FACTOR IX | |||
| FACTOR VIIA | |||
| FACTOR VIII | |||
| FACTOR VIII INHIBITOR BYPASSING FRACTION | |||
| FIBRINOGEN HUMAN | |||
| PROTHROMBIN COMPLEX CONCENTRATE | |||
| LIPID-REGULATING DRUGS | |||
| ATORVASTATIN | ALIROCUMAB | ||
| EZETIMIBE | BEMPEDOIC ACID | ||
| GEMFIBROZIL | CHOLESTYRAMINE | ||
| ROSUVASTATIN | EVOLOCUMAB | ||
| SIMVASTATIN | FENOFIBRATE | ||
| INCLISIRAN | |||
| LOCAL SCLEROSANTS | |||
| ETHANOLAMINE OLEATE | |||
| SODIUM TETRADECYL SULPHATE | |||
| MISCELLANEOUS (CARDIOVASCULAR SYSTEM) | |||
| ADENOSINE TRIPHOSPHATE DISODIUM | LEVOSIMENDAN | TAFAMIDIS | |
| CARDIOPLEGIA (OR EQUIV) | MAVACAMTEN | ||
| DAFLON (OR EQUIV) | TRIMETAZIDINE | ||
| TISSEEL KIT (OR EQUIV) | |||
| UBIDECARENONE | |||